These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8999716)

  • 21. [DNA topoisomerase I--targeting drugs].
    Arakawa Y
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():174-7. PubMed ID: 25831746
    [No Abstract]   [Full Text] [Related]  

  • 22. Irinotecan for colorectal cancer: a small step forward.
    O'Connell MJ
    Lancet; 1998 Oct; 352(9138):1402. PubMed ID: 9807982
    [No Abstract]   [Full Text] [Related]  

  • 23. [Development of cancer chemotherapy. Discovery of new active drugs. IV].
    Lopez M
    Clin Ter; 1999; 150(3):241-9. PubMed ID: 10528439
    [No Abstract]   [Full Text] [Related]  

  • 24. Camptothecins: new enthusiasm for an old drug.
    Rowe PM
    Lancet; 1996 Mar; 347(9005):892. PubMed ID: 8622402
    [No Abstract]   [Full Text] [Related]  

  • 25. Are there any better camptothecins than the ones we have?
    Takimoto CH
    Clin Adv Hematol Oncol; 2003 Oct; 1(10):578-9, 600. PubMed ID: 16258452
    [No Abstract]   [Full Text] [Related]  

  • 26. Premedication for irinotecan.
    Zampa G; Magnolfi E; Borgomastro A
    J Clin Oncol; 2000 Jan; 18(1):237. PubMed ID: 10623719
    [No Abstract]   [Full Text] [Related]  

  • 27. DNA topoisomerase I inhibitors.
    Takimoto CH; Kieffer LV; Arbuck SG
    Cancer Chemother Biol Response Modif; 1997; 17():80-113. PubMed ID: 9551210
    [No Abstract]   [Full Text] [Related]  

  • 28. Acute presentation of rheumatoid arthritis following cancer chemotherapy using the topoisomerase I inhibitor irinotecan.
    Yau TC; Chu KW; Mok MY; Liang RH; Epstein RJ
    Acta Oncol; 2005; 44(7):771-2. PubMed ID: 16227172
    [No Abstract]   [Full Text] [Related]  

  • 29. [Topoisomerase inhibitors developing in Japan].
    Furue H
    Gan To Kagaku Ryoho; 1993 Jan; 20(1):42-9. PubMed ID: 8422186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Current status of camptothecin derivatives as natural antitumor agents].
    Pan XD; Wang CY
    Yao Xue Xue Bao; 2003 Sep; 38(9):715-20. PubMed ID: 14730926
    [No Abstract]   [Full Text] [Related]  

  • 31. Therapeutic efficacy of the topoisomerase I inhibitor 7-ethyl-10-(4-[1-piperidino]-1-piperidino)-carbonyloxy-camptothecin against human tumor xenografts: lack of cross-resistance in vivo in tumors with acquired resistance to the topoisomerase I inhibitor 9-dimethylaminomethyl-10-hydroxycamptothecin.
    Houghton PJ; Cheshire PJ; Hallman JC; Bissery MC; Mathieu-Boué A; Houghton JA
    Cancer Res; 1993 Jun; 53(12):2823-9. PubMed ID: 8504425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy and toxicity of belotecan (CKD-602), a camptothericin analogue topoisomerase I inhibitor, in patients with recurrent or refractory epithelial ovarian cancer.
    Kim YM; Lee SW; Kim DY; Kim JH; Nam JH; Kim YT
    J Chemother; 2010 Jun; 22(3):197-200. PubMed ID: 20566426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Camptothecins in clinical development.
    Zunino F; Pratesi G
    Expert Opin Investig Drugs; 2004 Mar; 13(3):269-84. PubMed ID: 15013945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preclinical and clinical development of camptothecins.
    Costin D; Potmesil M
    Adv Pharmacol; 1994; 29B():51-72. PubMed ID: 8996601
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical studies of camptothecin and derivatives.
    Soepenberg O; Sparreboom A; Verweij J
    Alkaloids Chem Biol; 2003; 60():1-50. PubMed ID: 14593855
    [No Abstract]   [Full Text] [Related]  

  • 36. CPT-11: a novel antitumor drug.
    Armand JP
    Jpn J Cancer Res; 1994 Aug; 85(8):inside front cover. PubMed ID: 7928619
    [No Abstract]   [Full Text] [Related]  

  • 37. [Irinotecan-containing combinations in solid tumors, except colonic carcinomas].
    Couteau C; Armand JP
    Bull Cancer; 1998 Dec; Spec No():47-50. PubMed ID: 9932085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An overview of topoisomerase I-targeting agents.
    Arbuck SG; Takimoto CH
    Semin Hematol; 1998 Jul; 35(3 Suppl 4):3-12. PubMed ID: 9779876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Irinotecan for metastatic colorectal cancer.
    Med Lett Drugs Ther; 1997 Jan; 39(992):8. PubMed ID: 9008684
    [No Abstract]   [Full Text] [Related]  

  • 40. [Taxotere (docetaxel) and CPT 11 (irinotecan): phase I trials].
    Couteau C; Yakendji K; Terret C; Goncalves E; Armand JP
    Bull Cancer; 1996 Jan; 83(1):3-10. PubMed ID: 8672854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.